Diffusion Pharmaceuticals Inc: Clinical Trials

5 trials sponsored by Diffusion Pharmaceuticals Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 2
Phase 13Completed 3

Follow Diffusion Pharmaceuticals Inc: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Trans Sodium Crocetinate, Placebo - Interstitial Lung Disease
Phase 2TerminatedDiffusion Pharmaceuticals Inc182021-12-022022-08-10
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
Trans Sodium Crocetinate, Normal saline - SARS-CoV-2 (Covid19)
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc252020-09-102022-04-14
Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke
Trans-Sodium Crocetinate, Placebo - Stroke, Acute
Phase 2TerminatedDiffusion Pharmaceuticals Inc62019-08-222021-06-18
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
Trans Sodium Crocetinate (TSC) - Glioblastoma, GBM
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc592012-02-012017-07-14
Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication
Trans sodium crocetinate (TSC), 0.9% normal saline - Intermittent Claudication
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc482008-08-012011-07-29

Conditions studied

Atherosclerosis (1)  ·  Brain Neoplasms (1)  ·  COVID-19 (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Hypoxia (1)  ·  Intermittent Claudication (1)  ·  Lung Diseases, Interstitial (1)  ·  Peripheral Arterial Disease (1)  ·  Stroke (1)

Interventions

trans-sodium crocetinate (5)  ·  Saline Solution (2)  ·  Sodium Chloride (1)

Countries

United States (4)  ·  Romania (1)

Top investigators

Adrian Streinu Cercel, MD (1)  ·  Andrew Southerland, MD (1)  ·  David R. Jones, M.D. (1)  ·  Jeffrey Saver, MD (1)  ·  Karen Johnston, MD (1)  ·  Nerses Sanossian, MD (1)

Results publications

PMID 15758009, PMID 22003000, PMID 27177177, PMID 35369714